HDFC Mutual Fund and ADIA Invest ₹777 Crore in Pharma Firm Corona Remedies
Source: Economictimes
Major institutional investors, led by HDFC Mutual Fund and the Abu Dhabi Investment Authority (ADIA), have acquired stakes in Corona Remedies via a massive block deal. The shares were offloaded by existing investors Sepia Investments and Anchor Partners for approximately ₹777 crore.
- ▸HDFC Mutual Fund was the largest buyer in the ₹777 crore block deal for Corona Remedies.
- ▸Global giants like ADIA and Invesco have also picked up stakes, showing international confidence.
- ▸The sellers in this transaction were existing investors Sepia Investments and Anchor Partners.
- ▸This deal highlights a strong institutional interest in the Indian pharmaceutical sector.
- ✓HDFC Mutual Fund was the largest buyer in the ₹777 crore block deal for Corona Remedies.
- ✓Global giants like ADIA and Invesco have also picked up stakes, showing international confidence.
- ✓The sellers in this transaction were existing investors Sepia Investments and Anchor Partners.
- ✓This deal highlights a strong institutional interest in the Indian pharmaceutical sector.
Your dream home loan @ 8.4%*
Compare offers from 20+ banks in one click.
In a significant move within the Indian pharmaceutical landscape, several high-profile institutional investors have pooled their resources to pick up a substantial stake in Corona Remedies. The transaction, executed through block deals on the stock exchanges, underscores the growing appetite for established healthcare players among top-tier fund managers.
The Details of the Deal
Existing stakeholders Sepia Investments and Anchor Partners sold shares worth roughly ₹777 crore in the pharmaceutical company. While the exact percentage of the equity changed hands wasn't immediately specified, the sheer scale of the transaction—approaching nearly ₹800 crore—marks it as one of the notable institutional movements in recent weeks.
HDFC MF Leads the Buying Charge
HDFC Mutual Fund emerged as the most prominent buyer in this transaction, absorbing a significant portion of the offloaded shares. This move by India’s leading fund house suggests a strong conviction in the long-term growth prospects of Corona Remedies. By deploying capital here, HDFC MF’s fund managers are signaling that they see value in the company’s current market positioning.
Global Giants Join the Fray
The deal wasn't just limited to domestic players. A group of prestigious international and multi-strategy firms also participated in the buying spree, including:
- ADIA (Abu Dhabi Investment Authority): The sovereign wealth fund’s participation highlights global interest in Indian pharma.
- Aberdeen Entities: Known for their long-term investment approach.
- Invesco and WhiteOak: These institutional heavyweights further validated the demand for the stock.
What This Means for Retail Investors
When 'smart money'—represented by the likes of HDFC MF and ADIA—moves into a specific company, it often serves as a quality check for retail investors. While block deals involve large quantities of shares being traded between institutions, they reflect the underlying demand and trust in the company's financial health and future earnings potential. For retail participants, seeing such a diverse group of global and local institutions accumulate shares provides a layer of institutional validation for the pharmaceutical sector at large.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. This is for informational purposes only and not investment advice.
Some listings may be sponsored. Mutual fund data is from AMFI and for information only — funds are subject to market risks. Review terms & suitability before investing. Not investment advice.
Frequently Asked Questions
What is a block deal and why does it matter?
A block deal is a single transaction of a large number of shares (usually over 5 lakh shares or ₹5 crore in value) between two parties. It matters because it shows where large professional investors are putting their money.
Who are the major buyers in the Corona Remedies deal?
HDFC Mutual Fund was the lead buyer, joined by global entities such as ADIA (Abu Dhabi Investment Authority), Aberdeen, Invesco, and WhiteOak.
Does this mean I should immediately buy the stock?
Institutional interest is a positive sign, but retail investors should always check if the company aligns with their personal risk profile and financial goals before investing.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Mutual Funds
BreakingMF Giants Buy Over 1 Crore Shares in 6 Stocks; Yes Bank & Central Bank Top List
Mutual fund houses significantly ramped up their holdings in May, adding over 1 crore shares each in six specific stocks. This surge in institutional backing coincides with impressive price rallies of up to 25% in these counters.
Don't Rely Solely on Indian Markets: Why You Need Global Stocks in Your Portfolio
Financial experts are urging Indian investors to break their 'home-country bias' and diversify into international markets. By investing in global equities, retail investors can protect their wealth against domestic volatility, inflation, and currency fluctuations.
BreakingHidden Gems: 5 Stocks Favored by India’s Top 3 Smallcap Mutual Funds
India's three largest smallcap funds, managing over ₹1.5 lakh crore, have found common ground in five specific stocks. These 'under-the-radar' picks represent a rare consensus among top fund managers looking for long-term growth.
Related Stories
HDFC ಮ್ಯೂಚುಯಲ್ ಫಂಡ್ ಮತ್ತು ADIA ಫಾರ್ಮಾ ಸಂಸ್ಥೆ ಕೊರೋನಾ ರೆಮಿಡೀಸ್ನಲ್ಲಿ ₹777 ಕೋಟಿ ಹೂಡಿಕೆ ಮಾಡಿದೆ
HDFC ಮ್ಯೂಚುಯಲ್ ಫಂಡ್ ಮತ್ತು ಅಬುಧಾಬಿ ಇನ್ವೆಸ್ಟ್ಮೆಂಟ್ ಅಥಾರಿಟಿ (ADIA) ನೇತೃತ್ವದ ಪ್ರಮುಖ ಸಾಂಸ್ಥಿಕ ಹೂಡಿಕೆದಾರರು ಬೃಹತ್ ಬ್ಲಾಕ್ ಡೀಲ್ ಮೂಲಕ ಕೊರೋನಾ ರೆಮಿಡೀಸ್ನಲ್ಲಿ ಪಾಲನ್ನು ಪಡೆದುಕೊಂಡಿದ್ದಾರೆ. ಅಸ್ತಿತ್ವದಲ್ಲಿರುವ ಹೂಡಿಕೆದಾರರಾದ ಸೆಪಿಯಾ ಇನ್ವೆಸ್ಟ್ಮೆಂಟ್ಸ್ ಮತ್ತು ಆಂಕರ್ ಪಾರ್ಟ್ನರ್ಸ್ ಸುಮಾರು ₹777 ಕೋಟಿ ಮೊತ್ತದ ಷೇರುಗಳನ್ನು ಮಾರಾಟ ಮಾಡಿದ್ದಾರೆ.
एचडीएफसी म्युच्युअल फंड आणि ADIA कडून फार्मा कंपनी कोरोना रेमेडीजमध्ये ₹७७७ कोटींची गुंतवणूक
एचडीएफसी म्युच्युअल फंड आणि अबु धाबी इन्व्हेस्टमेंट अथॉरिटी (ADIA) यांच्या नेतृत्वाखालील प्रमुख संस्थात्मक गुंतवणूकदारांनी एका मोठ्या ब्लॉक डीलद्वारे कोरोना रेमेडीजमधील हिस्सा खरेदी केला आहे. विद्यमान गुंतवणूकदार सेपिया इन्व्हेस्टमेंट्स आणि अँकर पार्टनर्स यांनी अंदाजे ₹७७७ कोटींचे शेअर्स विकले आहेत.
HDFC Mutual Fund और ADIA ने फार्मा कंपनी Corona Remedies में ₹777 करोड़ का निवेश किया
HDFC Mutual Fund और Abu Dhabi Investment Authority (ADIA) के नेतृत्व में प्रमुख संस्थागत निवेशकों ने एक विशाल ब्लॉक डील (block deal) के माध्यम से Corona Remedies में हिस्सेदारी हासिल की है। ये शेयर मौजूदा निवेशकों Sepia Investments और Anchor Partners द्वारा लगभग ₹777 करोड़ में बेचे गए।
BreakingMF दिग्गजों ने 6 शेयरों में खरीदे 1 करोड़ से अधिक शेयर; Yes Bank और Central Bank लिस्ट में सबसे ऊपर
मई में म्यूचुअल फंड हाउसों ने अपनी होल्डिंग में उल्लेखनीय वृद्धि की, छह विशिष्ट शेयरों में प्रत्येक में 1 करोड़ से अधिक शेयर जोड़े। संस्थागत समर्थन में यह उछाल इन काउंटरों में 25% तक की शानदार मूल्य रैली के साथ मेल खाता है।